These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Going Germline: Mitochondrial Replacement as a Guide to Genome Editing. Adashi EY; Cohen IG Cell; 2016 Feb; 164(5):832-5. PubMed ID: 26919419 [TBL] [Abstract][Full Text] [Related]
30. Engineered CRISPR Systems for Next Generation Gene Therapies. Pineda M; Moghadam F; Ebrahimkhani MR; Kiani S ACS Synth Biol; 2017 Sep; 6(9):1614-1626. PubMed ID: 28558198 [TBL] [Abstract][Full Text] [Related]
31. Beyond CRISPR: A guide to the many other ways to edit a genome. Ledford H Nature; 2016 Aug; 536(7615):136-7. PubMed ID: 27510203 [No Abstract] [Full Text] [Related]
32. The CRISPR Conundrum: As Millions of Dollars Flow into Developing the Gene-Editing Tool, Scientists Continue to Discover the Technology's Potential and Pitfalls. Bates M IEEE Pulse; 2016; 7(2):17-21. PubMed ID: 26978846 [TBL] [Abstract][Full Text] [Related]
33. In vivo imaging of gene expression: Bremer C; Weissleder R Acad Radiol; 2001 Jan; 8(1):15-23. PubMed ID: 11201452 [TBL] [Abstract][Full Text] [Related]
34. The future of gene therapy in the UK. Seymour LW Trends Biotechnol; 2006 Aug; 24(8):347-9. PubMed ID: 16782218 [TBL] [Abstract][Full Text] [Related]
35. From Genomics to Gene Therapy: Induced Pluripotent Stem Cells Meet Genome Editing. Hotta A; Yamanaka S Annu Rev Genet; 2015; 49():47-70. PubMed ID: 26407033 [TBL] [Abstract][Full Text] [Related]
36. Uses and abuses of human gene transfer. Anderson WF Hum Gene Ther; 1992 Feb; 3(1):1-2. PubMed ID: 1562636 [No Abstract] [Full Text] [Related]
37. Treatment of chronic wounds: state of the art and future concepts. Eming SA; Smola H; Krieg T Cells Tissues Organs; 2002; 172(2):105-17. PubMed ID: 12426487 [TBL] [Abstract][Full Text] [Related]
38. [New scenarios for medical science]. Esposito S Infez Med; 2001 Mar; 9(1):5-6. PubMed ID: 12116953 [No Abstract] [Full Text] [Related]
39. Apoptotic genes in cancer therapy. Opalka B; Dickopp A; Kirch HC Cells Tissues Organs; 2002; 172(2):126-32. PubMed ID: 12426489 [TBL] [Abstract][Full Text] [Related]
40. Application of CRISPR/Cas9 genome editing to the study and treatment of disease. Pellagatti A; Dolatshad H; Valletta S; Boultwood J Arch Toxicol; 2015 Jul; 89(7):1023-34. PubMed ID: 25827103 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]